Sputum smear conversion and treatment outcomes for tuberculosis patients with and without diabetes in Fiji
Objectives: To determine the prevalence of diabetes mellitus (DM) among TB patients for the period 2010–2012, and to evaluate sputum smear conversion and anti-tuberculosis treatment outcomes, comparing patients with and without DM.
Design: A retrospective descriptive study using routinely collected data from the TB register and in-patient folders.
Results: Of 577 TB patients identified, information on DM was available for 567 (98%), of whom 68 (12%) had DM. Smear status at 2 months was available for 254 (82%) patients with sputum smear-positive pulmonary TB. The sputum smear conversion rate (from positive to negative) was equivalent in TB patients with and without DM (78% vs. 80%, P = 0.66). Anti-tuberculosis treatment outcome information was available for 462 patients; the difference in outcome comparing successfully treated patients with those unsuccessfully treated was not statistically significant (91% in TB patients with DM vs. 84% in TB patients without DM, P = 0.06).
Conclusion: DM is common among TB patients in Fiji. Sputum smear conversion rates were not different in TB patients with and without DM; no difference in treatment success between the two groups was observed.
Keywords: Fiji; diabetes mellitus; treatment outcomes; tuberculosis
Document Type: Research Article
Affiliations: 1: College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji 2: National Tuberculosis Programme, Fiji Ministry of Health, Suva, Fiji 3: Public Health Division, Secretariat of the Pacific Community, Nouméa, New Caledonia, National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia
Publication date: 21 September 2014
Public Health Action (PHA), The Union's quarterly Open Access journal, welcomes the submission of articles on operational research. It publishes high-quality scientific research on health services, providing new knowledge on how to improve access, equity, quality and efficiency of health systems and services.
The Editors will consider any manuscript reporting original research on quality improvements, cost-benefit analysis, legislation, training and capacity building, with a focus on all relevant areas of public health (e.g. infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance, outbreaks etc).
- Editorial Board
- Information for Authors
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites